Back to Market返回行情

VREOF Vireo Growth Inc.

OTCHealthcare

$12.58+2964.33%ClosedMarket Cap: $14.43B

As of 2026-06-04 16:00

Income Statement

Periods shown are fiscal year quarters (may differ from calendar year)

Period	Revenue	Gross Margin	Operating Income	Net Income	EPS	Dividend
Q1 2026	$106.2M	55.8%	$17.5M	$-20.0M	$-0.02	—
Q4 2025	$104.5M	54.4%	$2.6M	$-20.4M	$-0.02	—
Q3 2025	$91.7M	40.8%	$1.6M	$-26.3M	$-0.03	—
Q2 2025	$48.1M	42.5%	$-2.0M	$-14.9M	$-0.03	—
Q1 2025	$24.5M	50.6%	$2.0M	$-6.5M	$-0.02	—
Q4 2024	$25.0M	50.6%	$-842.0K	$-15.7M	$-0.07	—
Q3 2024	$25.2M	49.0%	$3.9M	$-4.9M	$-0.02	—
Q2 2024	$25.1M	54.0%	$5.8M	$-668.0K	$-0.00	—
Q1 2024	$24.0M	51.1%	$4.7M	$-6.7M	$-0.05	—
Q4 2023	$24.2M	49.9%	$5.4M	$-4.6M	$-0.03	—
Q3 2023	$24.7M	53.5%	$5.9M	$-5.2M	$-0.04	—
Q2 2023	$20.2M	46.2%	$-1.0M	$-7.3M	$-0.06	—